Drug Regulations: FDA Proposes Ban on Bulk Semaglutide/Tirzepatide Compounding FDA Ban on Compounded Semaglutide – If you’ve been getting your Ozempic, Wegovy, or Mounjaro through a compounding pharmacy, a quiet regulatory shift might upend your access — and your budget. On April 30, 2026, the FDA announced it is considering removing the active ingredients in … Continue reading FDA Ban on Compounded Semaglutide: 7 Critical Facts Patients Must Know